Egypt
Research Article
Assessment of Bone Pain Response in Cancer Patients Receiving Single Dose of Sm-153 EDTMP Therapy
Author(s): Mai Elzahry, Waleed Diab and Helmut SinzingerMai Elzahry, Waleed Diab and Helmut Sinzinger
Background: Painful metastatic bone dissemination is a common complication of solid malignant tumors that can lead to severe morbidity. There are different treatment strategies currently available for pain relief. Among those, we obtained clinical experience with Sm-153 EDTMP.
Objective: It was to evaluate the overall therapeutic response in 110 patients who underwent a single dose of Sm-153 EDTMP therapy and report if there is a significant correlation of metastatic bone pain response with gender, pathology of primary cancer, patient’s age, extent of the metastatic bone dissemination.
Patients and methods: 110 cancer patients were included in this retrospective analysis, 63 (57.2%) males (age range; 52-89 years) and 47 (42.7%) females (age range: 35-84 y), their diagnosis were prostate and breast cancer, respectiv.. Read More»
DOI:
10.4172/2155-9619.1000349
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report